Influenza Vaccine Market for West Europe
Influenza vaccine market for West Europe was more than US$ 500 Million. United Kingdom is having the highest seasonal influenza vaccine market share followed by Germany and France respectively. In children vaccination, United Kingdom is the leader and France holds the second spot. In adult vaccination United Kingdom and Germany have a close fight for top slot. Download full Report: http://www.renub.com/influenza-vaccine-market-and-forecast-in-west-europe-netherlands-germany-france-ireland-luxembourg-poland-and-united-kingdom-by-child-and-adult-1061-p.php
Influenza vaccine market for West Europe was more than US$ 500 Million. United Kingdom is having the highest seasonal influenza vaccine market share followed by Germany and France respectively. In children vaccination, United Kingdom is the leader and France holds the second spot. In adult vaccination United Kingdom and Germany have a close fight for top slot.
Download full Report: http://www.renub.com/influenza-vaccine-market-and-forecast-in-west-europe-netherlands-germany-france-ireland-luxembourg-poland-and-united-kingdom-by-child-and-adult-1061-p.php
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Million US$<br />
<strong>Influenza</strong> <strong>Vaccine</strong> <strong>Market</strong> & Forecast in (<strong>West</strong> <strong>Europe</strong>) Netherlands, Germany, France, Ireland,<br />
<br />
Luxembourg, Poland and United Kingdom By (Child & Adult)<br />
<strong>Influenza</strong> Vaccinated Population & Forecast has been sub divided into two segments<br />
Children <strong>Influenza</strong> Vaccinated Population & Forecast and Adult <strong>Influenza</strong> Vaccinated<br />
Population & Forecast.<br />
<strong>Market</strong> Dynamics<br />
1 Seasonal <strong>Influenza</strong> <strong>Vaccine</strong> - Growth Drivers<br />
(a) <strong>Vaccine</strong> Manufacturers Plan to Increase Flu <strong>Vaccine</strong> Production<br />
(b) Growing Child & Ageing Population in <strong>West</strong>ern <strong>Europe</strong>an Region<br />
(c) Rising Healthcare Expenditure Share of the <strong>West</strong>ern <strong>Europe</strong> Countries GDP<br />
2 Seasonal <strong>Influenza</strong> <strong>Vaccine</strong> – Challenges<br />
(a) Regulatory Challenges with New and Novel <strong>Influenza</strong> <strong>Vaccine</strong>s<br />
(b) Lack of Healthcare Infrastructure<br />
(c) Limited Reimbursement and Access to the <strong>Vaccine</strong>s<br />
Countries Studied in the Report are As follows<br />
1. Netherlands<br />
2. Germany<br />
3. France<br />
4. Ireland<br />
5. Luxembourg<br />
6. Poland<br />
7. United Kingdom<br />
<strong>West</strong>ern <strong>Europe</strong> Countries - Seasonal <strong>Influenza</strong> <strong>Vaccine</strong> <strong>Market</strong> (Million US$), 2011 - 2016<br />
2,011 2,012 2,013 2,014 2,015 2,016<br />
Source: Renub Research Analysis<br />
© Renub Research LLP Page 2 of 3
Change language